Virax Biolabs Group Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Virax Biolabs Group Limited generated cash of -$6,247,016, which is less than the previous year. Cash used in financing activities reached the amount of $1,648,171 last year. Net change in cash is therefore -$5,763,294.
Cash Flow
| 2020 | -744.61K | 0 | 704.63K |
|---|---|---|---|
| 2021 | -590.18K | 0 | 585.19K |
| 2022 | -809.06K | 0 | 813.20K |
| 2023 | -4.17M | -178.40K | 13.68M |
| 2024 | -6.24M | -1.16M | 1.64M |
VRAX Cash Flow Statement (2020 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
Cash at beginning of period | 9.35M | 21.75K | 17.62K | 22.60K | 62.58K |
Operating activities | |||||
Net income | -6.73M | -5.45M | -1.70M | -650.98K | -739.46K |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 103.09K | 0 | 0 | 0 | 0 |
Stock-based compensation expense | 1.01M | 1.73M | 290.36K | 0 | 0 |
| Deferred income tax benefit | 1.01M | 1.73M | 290.36K | 0 | 0 |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | -217.84K | 0 | 928 | -928 | 0 |
Inventories | -60.38K | 20.95K | 121 | -21.07K | 0 |
Accounts payable | -572.24K | 33.94K | 641.15K | 81.61K | -96.82K |
Cash generated by operating activities | -6.24M | -4.17M | -809.06K | -590.18K | -744.61K |
Investing activities | |||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -952.49K | -178.40K | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -1.16M | -178.40K | 0 | 0 | 0 |
Financing activities | |||||
Common Stock Issued | 234 | 13.65M | 519.61K | 403.21K | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -206.27K | 146.25K | 100K | 0 | 0 |
Cash used in financing activities | 1.64M | 13.68M | 813.20K | 585.19K | 704.63K |
Net Change In Cash | -5.76M | 9.33M | 4.13K | -4.98K | -39.97K |
Cash at end of period | 3.58M | 9.35M | 21.75K | 17.62K | 22.60K |
| Data source | Data source | Data source |